BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2008
View Archived Issues
Effects of mycobacterial cell wall-DNA complex in bladder cancer not dependent on age
Read More
Hana completes phase I menadione trial in skin toxicity due to EGFR inhibitors
Read More
Viralytics to test Cavatak in head and neck cancer
Read More
Phosphagenics presents phase I clinical results for transdermal lidocaine
Read More
InSite Vision reports preliminary results from phase IIIa clinical trial of AzaSite Plus
Read More
AcelRx reports results from phase II clinical study of sufentanil in postoperative pain
Read More
BioWa licenses Potelligent to GSK for antibody development and commercialization
Read More
Portola commences phase II novel P2Y12 ADP receptor antagonist trial
Read More
Daiichi Sankyo initiates phase III DU-176b trial in patients with atrial fibrillation
Read More
Rib-X reports top-line results from phase II delafloxacin study
Read More
First-in-human study shows safety and biological effects of CSL-360 in acute myeloid leukemia
Read More
Pivotal studies to follow phase IIb trial of AP-12009 in glioma
Read More
Omeros presents results from phase I OMS-201 study
Read More
Preliminary phase II data suggest APD-125 did not meet trial endpoints
Read More
Recent Amgen patents describe novel treatments for anemia
Read More
Ferring and the Conaris Research Institute sign worldwide license agreement for FE-301
Read More
New antiglaucoma agents disclosed in recent Unimed patent
Read More
Recent ProMetic patent divulges novel agents for treatment of autoimmune diseases
Read More
Proteo and Minapharm receive approval in Cairo for Elafin phase II trial in kidney transplantation
Read More
Olanzapine long-acting injection approved in Europe for schizophrenia
Read More
Meda receives U.K. approval for ketoprofen/omeprazole combination
Read More
Perampanel well tolerated in phase II study in patients with refractory partial seizures
Read More
Abstral receives marketing approval in Germany for breakthrough cancer pain
Read More
Daiichi Sankyo submits application for approval of CS-866AZ in Japan
Read More
New data on JAK2 inhibitors from Exelixis presented at ASH meeting
Read More
Antileukemic effects of DCC-2036, DCC-2157 assessed in vivo
Read More
RAP-011 prevents skeletal metastases in a mouse model of metastatic breast cancer
Read More
